Administration of enteric-coated mycophenolate sodium in children with steroid-resistant nephrotic syndrome and focal segmental glomerulosclerosis

• Main Authors: Maria Gracia Caletti (Author), Juan Ibañez (Author), Paulo Caceres Guido (Author), Lilien Chertkoff (Author), Mara Bonetto (Author), Veronica Araoz (Author), Paula Schaiquevich (Author)
• Format: Book
• Published: Society of Diabetic Nephropathy Prevention, 2018-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Pediatric patients with steroid-resistant nephrotic syndrome (SRNS) and focal segmental glomerulosclerosis (FSGS) may relapse and current second line agents include mycophenolate mofetil. However, there is no current information about the use of the sodium salt of mycophenolic acid (SMPA...